Clinical Trial
Offered by: Nemours Children's
Location: Orlando, Fla.
Trial Name
A Multinational Trial Evaluating Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Patients With Hemophilia A
What is the trial about?
Study of children with severe hemophilia A.
Who can participate?
Male patients at least 12 years old.
What is involved?
Participation in this study will last about 6 months in the on-demand arm and about 7 to 19 months in the prophylaxis arm. There will be a total of up to 12 study visits each lasting no more than 2 hours each. Complete physical exam, and blood/urine samples.
Contact Nemours Children's Clinical Trials
Trial Name: A Multinational Trial Evaluating Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Patients with Hemophilia A
IRB#: 308004
Is a Clinical Trial Right for Your Child?
Learn more about clinical trials and get answers to questions you might have.
Go to FAQs View All Clinical Trials
Nemours has a number of service regions. Selecting your region will help us show you the right contact information and the most relevant content for you.